NovoCure NVCR
NASDAQ NVCR
$15.95 -0.04 (-0.25%)
At close: Sep 30, 2026 · 4:00 PM EDT

NovoCure (NVCR) EV to EBITDA (2019 - 2021)

Updated

NovoCure's (NVCR) EV to EBITDA was 9165.32 for Q3 2021, compared with 401.69 a year earlier and up 905.8% from the prior quarter.

Analysis

NovoCure (NVCR) EV to EBITDA (2019 - 2021) Analysis & Trends

Over the twelve months ended Sep 30, 2021, NovoCure's EV to EBITDA came in at 7018.69; for FY2020, it came in at 426.42, down 60.1% from FY2019.

  • By year, EV to EBITDA came in at 1068.27 in FY2019.
  • The Q3 2021 figure ranks as the highest quarterly EV to EBITDA in data going back to Q4 2019.
  • Per Business Quant data, the three quarters before Q3 2021 came in at 911.26 (Q2 2021), 294.86 (Q1 2021) and 426.42 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 NovoCure 1.86 Bn -491.82 Mn 142.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 9,165.32
Jun 30, 2021 911.26
Mar 31, 2021 294.86
Dec 31, 2020 426.42
Sep 30, 2020 401.69
Jun 30, 2020 348.75
Mar 31, 2020 627.53
Dec 31, 2019 1,068.27
API Access

NovoCure EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=NVCR&period=max&api_key=YOUR_API_KEY